首页> 外文期刊>Journal of Medicinal Chemistry >Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists
【24h】

Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists

机译:G蛋白偏倚的D2多巴胺受体部分激动剂的发现

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Biased ligands (also known as functionally selective ligands) of G protein-coupled receptors are valuable tools for dissecting the roles of G protein-dependent and independent signaling pathways in health and disease. Biased ligands have also been increasingly pursued by the biomedical community as promising therapeutics with improved efficacy and reduced side effects compared with unbiased ligands. We previously discovered first-in-class,beta-arrestin-biased agonists of dopamine D2 receptor (D2R) by extensively exploring multiple regions of aripiprazole, a balanced D2R agonist. In our continuing efforts to identify biased agonists of D2R, we unexpectedly discovered a G protein-biased agonist of D2R, compound 1, which is the first G protein-biased D2R agonist from the aripiprazole scaffold. We designed and synthesized novel analogues to explore two regions of 1 and conducted structure functional selectivity relationship (SFSR) studies. Here we report the discovery of 1, findings from our SFSR studies, and characterization of novel G protein-biased D2R agonists.
机译:G蛋白偶联受体的偏置配体(也称为功能选择性配体)是剖析G蛋白依赖性和独立信号通路在健康和疾病中的作用的重要工具。与无偏配体相比,生物医学界也越来越多地将偏配体作为有前途的治疗方法,以提高疗效和减少副作用。我们之前通过广泛研究阿立哌唑(一种平衡的D2R激动剂)的多个区域,发现了多巴胺D2受体(D2R)的一流的,β-arrestin偏置的激动剂。在我们继续努力确定D2R的激动剂激动剂中,我们意外地发现了D2R的G蛋白偏置的激动剂化合物1,这是阿立哌唑支架中的第一个G蛋白偏置的D2R激动剂。我们设计并合成了新颖的类似物,以探索1的两个区域,并进行了结构功能选择性关系(SFSR)研究。在这里,我们报告1的发现,来自我们的SFSR研究,以及新型G蛋白偏向D2R激动剂的表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号